胰岛素样生长因子1受体在胰腺癌治疗中的机制及进展

王悦超; 亓文骞; 赵平

doi:10.3969/j.issn.1001-5256.2017.04.043

胰岛素样生长因子1受体在胰腺癌治疗中的机制及进展

DOI: 10.3969/j.issn.1001-5256.2017.04.043

吉林大学中日联谊医院消化内科

详细信息

中图分类号: R735.9
计量
- 文章访问数: 1503
- HTML全文浏览量: 38
- PDF下载量: 398
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-13
- 出版日期: 2017-04-20

Research advances in insulin-like growth factor-1 receptor in pancreatic cancer

Department of Gastroenterology, China-Japan Union Hospital of Jilin University

摘要

摘要: 胰岛素样生长因子（IGF）1受体（IGF-1R）广泛存在于多种类型的细胞表面,与肿瘤细胞的形成、发展密切相关,也为肿瘤的靶向治疗提供了新的方向。对IGF-1R在胰腺癌中的表达、发生、发展以及IGF-1R作为靶点治疗肿瘤的进展作一综述。
- 受体,IGF 1型 /
- 胰腺肿瘤 /
- 综述
Abstract: Insulin-like growth factor-1 receptor ( IGF-1R) widely exists in the surface of various types of cells and is closely associated with the formation and development of tumor cells. It also provides a new direction for the targeted therapy for tumors. This article reviews the expression, development, and progression of IGF-1R in pancreatic cancer and research advances in IGF-1R as a target for tumor treatment.
- receptor, IGF type 1 /
- pancreatic neoplasms /
- review

HTML全文

参考文献(40)

[1]DAI B, WANG DS, ZHANG Y, et al.Research advances in the role of insulin-like growth factors in tumor[J/CD].Chin J Clinicians:Electronic Edition, 2013, 7 (15) :7099-7102. (in Chinese) 戴斌, 王德盛, 张勇, 等.胰岛素样生长因子家族在肿瘤中的作用研究进展[J/CD].中华临床医师杂志:电子版, 2013, 7 (15) :7099-7102.

[2]OUBAN A, MURACA P, YEATMAN T, et al.Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas[J].Hum Pathol, 2003, 34 (8) :803-808.

[3]JANEWAY KA, ZHU MJ, BARRETINA J, et al.Strong expression of IGF-1R in pediatric gastrointestinal stromal tumors without IGF-1R genomic amplification[J].Int J Cancer, 2010, 127 (11) :2718-2722.

[4]HAISA M.The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer[J].J Int Med Res, 2013, 41 (2) :253-264.

[5]CAO YH, XU CF.Insulin-like growth factor type 1 receptor and malignancy:an update[J].J Mod Oncol, 2015, 23 (5) :706-709. (in Chinese) 曹友红, 许春芳.胰岛素样生长因子-1受体在恶性肿瘤中的研究进展[J].现代肿瘤医学, 2015, 23 (5) :706-709.

[6]ADAMS TE, EPA VC, GARRETT TPJ, et al.Structure and function of the type 1 insulin-like growth factor receptor[J].Cell Mol Life Sci, 2000, 57 (7) :1050-1093.

[7]KING ER, WONG KK.Insulin-like growth factor:current concepts and new developments in cancer therapy[J].Recent Pat Anticancer Drug Discw, 2012, 7 (1) :14-30.

[8]CHAKRABORTY AK, WELSH A, DIGIOVANNA MP.Co-targeting the insulin-like growth factor 1 receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer celllines[J].Breast Cancer Res Treat, 2010, 120 (2) :327-335.

[9]MATSUDA Y, ICHIDA T.Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis[J].Med Mol Morphol, 2009, 42 (3) :138-142.

[10]KIM YH, SUMIYOSHI S, HASHIMOTO S, et al.Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer[J].Clin Lung Cancer, 2012, 13 (5) :385-390.

[11]YAMAMOTO T, OSHIMA T, YOSHIHARA K, et al.Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer[J].Exp Ther Med, 2012, 3 (5) :797-802.

[12]RYAN CJ, HAQQ CM, SIMKO J, et al.Expression of insulin-like growth faetor-I receptor in local and metastatic prostate cancer[J].Urol Oncol, 2007, 25 (2) :134-140.

[13]LUO M, SHEN DX, ZHOU XN, et al.MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor[J].Surgery, 2013, 153 (6) :836-847.

[14]PAN C, YANG SY, YIN SH, et al.Heat shock protein 90αand Insulin-like growth factor-1 receptor (IGF-1R) on expression level and clinicopathologic data in pancreatic cancer[J].Zhejiang Clin Med J, 2015, 17 (10) :1663-1665. (in Chinese) 潘超, 杨世勇, 殷少华, 等.HSP90α和IGF-1R在胰腺癌组织中的表达及临床意义[J].浙江临床医学, 2015, 17 (10) :1663-1665.

[15]LI H, LI J, LIU X.et al.Effect of PTEN and KAll gene overexpression on the proliferation, metastasis and radiosensitivity of ASPC1pancreatic cancer cells under hypoxic conditions[J].Mol Med Rep, 2014, 10 (4) :1973-1977.

[16]AMSTERDAM A, SHPIGNER L, RAANAN C, et al.Dynarmc distribution of ERK, p38 and JNK during the development of pancreatic ductal adenocarcinoma[J].Aeta Histochem, 2014, 116 (8) :1434-1442.

[17]REDLAK MJ, MILLER TA.Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis[J].Dig Dis Sci, 2011, 56 (2) :323-329.

[18]BREINIG M, MAYER P, HARJUNG A, et al.Heat shock protein90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors[J].Clin Cancer Res, 2011, 17 (8) :2237-2249.

[19]XU W, NECKERS L.Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells[J].Clin Cancer Res, 2007, 13 (6) :1625-1629.

[20]XU JW, WANG TX, YOU L, et al.Insulin-like growth factor 1receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer[J].PLo S One, 2014, 9 (3) :e92847.

[21]STOEHZING O, LIU W, REINMUTH N, et al.Regulation of hypoxia inducible factor-1 alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like factor 1 receptor autocrine loop in human pancreatic cancer[J].Am J Pathol, 2003, 163 (3) :1001-1011.

[22]HUANG PZ, HE T.Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma[J].Eur J Gynaecol Oncol, 2011, 32 (6) :660-664.

[23]TANG YC, ZHANG DL, FALLAVOLLITA L, et al.Vascular endothelial growth factor C expression and lymph nodc metastasis are regula Ied by the type 1 insulin-like growth factor receptor[J].Cancer Res, 2003, 63 (6) :1166-1171.

[24]LEE CT, PARK KH, ADACHI Y, et al.Recombinant adenoviruses expressing dominant negative insulin-like growth factor-1 receptor demonstrate antitumor effects on lung cancer[J].Cancer Gene Ther, 2003, 10 (1) :57-63.

[25]HARTOG H, WESSCLING J, BOEZEN HM, et al.The insulinlike growth factor l receptor in cancer old focus, new future[J].Eur J Cancer, 2007, 43:1895-1904.

[26] STOELTZING O, LIU W, REINMUTH N, et al.Regulation of hipoxia-inducibal factor-1alpha, vascular endothelial growth factor and angiogenesis by a insulin-like growth factor-l receptor in autocrine loop in human pancreatic cancer[J].Am J Panthol, 2003, 163 (3) :1001-1011.

[27]Mc KINLEY ET, BUGAJ JE, ZHAO P, et al.18FDG-PET predicts pharmacodynamic response to OSI-906, a Dual IGF-1R/IR inhibitor, inpreclinical mouse models of lung cancer[J].Clin Cancer Res, 2011, 17 (10) :3332-3340.

[28]ZHAO H, DESAI V, WANG J, et al.Epithelial-mesenchyma transition predicts sensitivity to the duaf IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines[J].Mol Cancer Ther, 2012, 11 (2) :503-513.

[29]HALUSKA P, CARBONI JM, LOEGERING DA, et al.In vitro and in vivo antitumor effects of the dual in sulin-like growth factor-1/insulin receptor inhibitor, BMS-554417[J].Anti Cancer Res, 2006, 66 (28) :362-371.

[30]MULVIHILL MJ, COOKE A, ROSENFEL-FRANKLIN M, et al.Discovery of OSI-906:a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor[J].Future Med Chem, 2009, 1 (6) :1153-1171.

[31]ZHOU H, RAO J, LIN J, et al.The insulin-like growth factor-1 receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastomato the effects of chemotherapy[J].Oncol Rep, 2011, 25 (6) :1565-1571.

[32]YEH J, LITZ J, HAUCK P, et al.Selective inhibition of SCLC growth by the A12 anti-IGF-1R monaclonal antibody correlates with inhibition of Akt[J].Lung Cancer, 2008, 60 (2) :166-174.

[33]WEST HJ.Novel targeted agents for lung cancer[J].Clin Lung Cancer, 2009, 10 (1) :41-46.

[34]SHIN DH, MIN HY, EL-NAGGAR AK, et al.Akt/m TOR counteract the antitumor activities of cixutumumab, an anti-insulinlike growth factor I receptor monoclonal antibody[J].Mol Cancer Ther, 2011, 10 (12) :2437-2448.

[35]ATTIAS-GEVA Z, BENTOV I, LUDWIG DL, et al.Insulinlike growth factor-I receptor (IGF-IR) targeting with monoclona I antibody cixutumumab (1MC-A12) inhibits IGF-1action in endonletria I cancer cells[J].Eur J Cancer, 2011, 47 (11) :1717-1726.

[36]MENDIVIF A, ZHOU C, CANTRELL LA, et a I.AMG 479, a novel l GF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways[J].Reprod Sci, 2011, 18 (9) :832-841.

[37]ZAMECNIK PC, STEPHENSON ML.Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynuclleotide[J].Proc Natl Acad Sci USA, 1978, 75 (1) :280-284.

[38]PAN YZ, SUN CY, WANG YZ.Growth inhibition of human pancreatic cancer cells by lipofection mediated IGF-1R antisense oligodeoxynucletides in combination with ionizing radiation[J].Chin J Radiological Med Prot, 2003, 24 (2) :114-116. (in Chinese) 潘耀振, 孙诚谊, 王玉芝.脂质体介导的IGF-1R反义寡核苷酸对胰腺癌细胞生长的抑制作用[J].中华放射医学与防护杂志, 2003, 24 (2) :114-116.

[39] WANG ZY.The anticancer research of antisense oligonucleotides targeting insulin-like growth factor 1 receptor[D].Beijing:Inst Radiat Med, China Acad Mil Med Sci, 2006:1-70. (in Chinese) 王芝艳.靶向胰岛素样生长因子1型受体的反义寡核苷酸抗肿瘤治疗[D].北京:军事医学科学院放射与辐射医学研究所, 2006:1-70.

[40]BAI S, NASSER MW, WANG B, et al.MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J].J Biol Chem, 2009, 284 (46) :32015-32027.

施引文献

资源附件(0)

访问统计